This Glossary provides an alphabetic list of specialized terminology that appears in this course. For much more exhaustive word references, please consult the Canadian Cancer Society’s Glossary at http://info.cancer.ca/e/glossary/glossary.html, or the National Cancer Institute’s Dictionary of Cancer Terms at http://www.cancer.gov/dictionary
Assessment: As one of the core functions of public health, assessment involves the systematic collection and analysis of data in order to provide a basis for decision making.This may include collecting statistics on local health status, health needs, and/or other public health issues.
Cancer Control: The reduction of cancer incidence, morbidity, and mortality through an orderly sequence of activities from research on interventions and their impact in defined populations to the broad, systematic application of theresearch results to prevent and treat cancer.
Cancer Experience Continuum: Six major phases in the experience of dealing with cancer – prevention, screening, diagnosis, treatment, survivorship, and palliation.
Cancer Sites: locations within the body where specific types of cancer are known to occur. Examples are the breast, colon, rectum, skin, prostate, and so on.
CCAN: Canadian Cancer Action Network
Chemotherapy: The use of drugs to treat cancer.
Clinical Trial: A research study that tests a new treatment or approach to detecting, reducing the risk for and managing cancer, which may prove to be better than current methods. Strict rules are followed to make sure participants are well informed about the purpose, risks and benefits of any study before they agree to join a clinical trial.
Cost–effectiveness: Compares relative costs and outcomes of different interventions.
CPAC: Canadian Partnership Against Cancer
Evidence–based Medicine (EBM): applies the best available evidence gained from the scientific method to medical decision making. EBM seeks to clarify those parts of medical practice that are in principle subject to scientific methods and to apply these methods to ensure the best prediction of outcomes in medical treatment.
Health Technology Assessment (HTA): a methodology that supports decision making regarding the adoption of new health technologies such as drugs or medical devices by bringing together many inputs such as scientific and economic analyses, as well as the needs and perspectives of patient and community groups.
PVN: Patient Voice Network. The network of Patient Voice Representatives across Canada.
PVR: Patient Voice Representative. An individual, usually a cancer survivor him orherself, who represents other patients on boards, advisory committees, and in avariety of other settings.
Stage: A description of the extent of a cancer within the body. Staging is based on the size of the tumour, the amount of spread to local tissues, involvement of the lymph nodes, and whether or not the disease has spread to other parts of the body. Each cancer type is staged according to its own criteria.
Systematic Review: A literature review focused on a research question that tries to identify, appraise, select and synthesize all high quality research evidence relevant to that question. Systematic reviews of high-quality randomized controlled trials are crucial to evidence-based medicine.
Therapy: The treatment of disease.
Treatment: interventions to cure disease, prolong life, and improve the quality of remaining life after a diagnosis of cancer has been confirmed.
Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, practicability, etc., of these interventions in individual cases or series.
Tumour: An abnormal growth of cells. Tumours can be non-cancerous (benign) orcancerous (malignant).